How many 8-K filings has Oncology Institute, Inc. filed?

Oncology Institute, Inc. (TOIIW) has 21 8-K (Current Event Report) filings on record, spanning Mar 2024 to Dec 2025.

What is a 8-K filing?

A 8-K is an SEC filing known as "Current Event Report." Filed to announce significant events or material changes such as acquisitions, executive departures, earnings announcements, or bankruptcy filings.

Where can I read Oncology Institute, Inc. 8-K filings in plain English?

ReadTheFiling provides AI-powered plain-English summaries of all Oncology Institute, Inc. 8-K filings, including risk assessment, sentiment analysis, and key financial figures.

Oncology Institute, Inc. (TOIIW) — 8-K Filings

All 8-K filings from Oncology Institute, Inc.. Browse 21 Current Event Report reports with AI-powered summaries and risk analysis.

8-K Filings (21)

8-K Filing — Dec 1, 2025
Oncology Institute Files 8-K Report — Nov 14, 2025 Risk: low
On November 14, 2025, The Oncology Institute, Inc. filed an 8-K report. The filing primarily concerns financial statements and exhibits, with no specific materi
Oncology Institute, Inc. Files 8-K — Nov 13, 2025 Risk: low
On November 13, 2025, The Oncology Institute, Inc. filed an 8-K report. The filing indicates the company's previous name was DFP HEALTHCARE ACQUISITIONS CORP.,
Oncology Institute Files 8-K — Nov 6, 2025 Risk: low
On November 3, 2025, The Oncology Institute, Inc. filed an 8-K report. The filing primarily concerns Regulation FD disclosures and financial statements and exhi
Oncology Institute Appoints New Directors, Sees Officer Departures — Aug 13, 2025 Risk: medium
Oncology Institute, Inc. announced on August 8, 2025, the departure of director Dr. David L. Smith. The company also elected Dr. Michael J. O'Connell and Ms. Je
Oncology Institute Files 8-K Report — May 19, 2025 Risk: low
On May 19, 2025, The Oncology Institute, Inc. filed an 8-K report. The filing primarily concerns Regulation FD Disclosure and Financial Statements and Exhibits.
Oncology Institute Files 8-K on Financials — May 14, 2025 Risk: low
On May 14, 2025, The Oncology Institute, Inc. filed an 8-K report detailing results of operations and financial condition. The company, formerly known as DFP He
Oncology Institute Files 8-K on Security Holder Vote Matters — May 8, 2025 Risk: low
On May 7, 2025, The Oncology Institute, Inc. filed an 8-K report detailing a submission of matters to a vote of security holders. The company, formerly known as
Oncology Institute Files 8-K on Director/Officer Changes — May 7, 2025 Risk: low
Oncology Institute, Inc. (TOI) filed an 8-K on May 7, 2025, reporting events as of May 2, 2025. The filing covers the departure of directors, election of direct
Oncology Institute, Inc. Formerly DFP Healthcare Acquisitions Corp. — Apr 11, 2025 Risk: low
On April 9, 2025, The Oncology Institute, Inc. filed an 8-K report. The filing indicates that the company was formerly known as DFP Healthcare Acquisitions Corp
Oncology Institute, Inc. Files 8-K with Material Agreement — Mar 27, 2025 Risk: medium
On March 26, 2025, The Oncology Institute, Inc. entered into a Material Definitive Agreement. The company also reported on unregistered sales of equity securiti
Oncology Institute, Inc. Files 8-K with Material Agreements — Mar 25, 2025 Risk: medium
On March 24, 2025, Oncology Institute, Inc. (TOI) entered into a Material Definitive Agreement. The company also disclosed unregistered sales of equity securiti
Oncology Institute, Inc. Files 8-K — Mar 24, 2025 Risk: low
On March 24, 2025, The Oncology Institute, Inc. filed an 8-K report. The filing indicates the company's fiscal year ends on December 31st. Previously, the compa
Oncology Institute Files 8-K Material Agreement — Feb 26, 2025 Risk: medium
On February 26, 2025, The Oncology Institute, Inc. filed an 8-K report detailing a material definitive agreement. The company, formerly known as DFP Healthcare
Oncology Institute Faces Nasdaq Delisting Concern — Dec 19, 2024 Risk: medium
On December 19, 2024, The Oncology Institute, Inc. filed an 8-K report to address its potential delisting from the Nasdaq Capital Market. The company is facing
Oncology Institute Appoints New CMO, Adds Directors — Nov 12, 2024 Risk: medium
On November 8, 2024, The Oncology Institute, Inc. announced the appointment of Dr. Robert L. Ferris as Chief Medical Officer and the election of Ms. Jennifer L.
Oncology Institute Files 8-K: Board Changes & Executive Comp — Sep 23, 2024 Risk: medium
On September 19, 2024, The Oncology Institute, Inc. filed an 8-K report detailing changes in its board of directors and executive compensation. The filing inclu
Oncology Institute Faces Delisting Concerns — Jun 21, 2024 Risk: high
On June 20, 2024, The Oncology Institute, Inc. filed an 8-K report indicating a potential delisting or failure to meet continued listing standards. The company
Oncology Institute Schedules Shareholder Vote — Jun 13, 2024 Risk: low
On June 13, 2024, The Oncology Institute, Inc. filed an 8-K report detailing the submission of matters to a vote of its security holders. This filing indicates
Oncology Institute, Inc. Formerly DFP Healthcare Acquisitions Corp. — Apr 3, 2024 Risk: low
On April 3, 2024, The Oncology Institute, Inc. filed an 8-K report. The filing indicates that the company was formerly known as DFP Healthcare Acquisitions Corp
Oncology Institute Files 8-K on Financials — Mar 27, 2024 Risk: low
On March 27, 2024, The Oncology Institute, Inc. filed an 8-K report. The filing primarily concerns the company's results of operations and financial condition,

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX